Samuel Dubrow, MD
Orthopaedic Surgery · Omaha, NENPI 1639349590
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,313 of the $34,236 with a category attached, or 65.2%. Arthrex accounts for 89.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $14,940 and has fallen 96.3% since, to $559 in 2025. Among orthopaedic surgery clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $241.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$31K
- Conetic Solutions, Inc.$1K
- Encore Medical, LP$1K
- Stryker$957
- Johnson & Johnson$122
- Catalyst Orthoscience$47
- plus $88 from 4 others
What the payments were for
- Speaking & faculty fees$22,31365%
- Travel & lodging$6,88220%
- Food & beverage$5,04115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 100 | $30,751 |
| Conetic Solutions, Inc. | 23 | $1,259 |
| Encore Medical, LP | 3 | $1,013 |
| Stryker | 10 | $957 |
| Johnson & Johnson | 1 | $122 |
| Catalyst Orthoscience | 1 | $47 |
| RSW Medical Company, Inc. | 1 | $30 |
| Smith+Nephew | 1 | $23 |
| Si-bone, Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO Surgical AltiVate Anatomic System$866
- DJO Surgical AltiVate Reverse$295
- AXSOS$175
- AUGMENT INJECTABLE$175
- PROPHECY$175
- INSPACE$171
- AEQUALIS PERFORM$164
- MAKO$160
- PANGEA$158
- ARTHREX$130
- NA$122
How this compares
$34,236 in reported general payments places this provider in the 90th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $532 |
| Celecoxib | 22 | $415 |
| Ibuprofen | 35 | $373 |
| Cyclobenzaprine Hcl | 53 | $353 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $287 |
| Oxycodone Hcl | 23 | $170 |
| Tizanidine Hcl | 17 | $126 |
| Tramadol Hcl | 20 | $95 |
| Methylprednisolone | 14 | $86 |
| Minocycline Hcl | 15 | $82 |
| Meloxicam | 16 | $82 |
| Cephalexin | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Omaha
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$475K
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- Matthew DilisioOmaha$58K
- Jonathan BuzzellOmaha$33K
- Michael StojanovicOmaha$22K
- Kirk HuttonOmaha$15K
- Sean McGarryOmaha$12K
- Clayton ThorOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.